| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.02B | $1.70B | $1.43B |
| YoY Revenue Growth % | +18.8% | +18.7% | — |
| Gross Profit | $1.65B | $1.38B | — |
| Gross Margin % | 81.6% | 81.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $245.4M | $179.4M | $128.4M |
| Operating Margin % | 12.2% | 10.6% | 9.0% |
| Net Income (GAAP) | $163.0M | $484.0M | $155.0M |
| EBITDA (Normalized) | $271.1M | $200.3M | $179.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $561.9M | $459.4M | $378.1M |
| Capital Expenditures (CapEx) | $32.2M | $26.1M | $64.4M |
| Free Cash Flow (FCF) | $529.7M | $433.3M | $313.7M |
| FCF Margin % | 26.2% | 25.5% | 21.9% |
| Return on Invested Capital (ROIC %) | 8.6% | 6.5% | 1.7% |
| Cash & Short-Term Equivalents | $1.09B | $907.5M | — |
| Total Debt (Short + Long Term) | $608.2M | $531.8M | $2.27B |
| Total Stockholders' Equity | $2.75B | $2.55B | $4.65B |